These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


356 related items for PubMed ID: 8901987

  • 21. Clinical potential of intravenously administered perfluorocarbons.
    Habler O, Kleen M, Messmer K.
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Artificial oxygen carriers as a possible alternative to red cells in clinical practice.
    Barbosa FT, Jucá MJ, Castro AA, Duarte JL, Barbosa LT.
    Sao Paulo Med J; 2009 May; 127(2):97-100. PubMed ID: 19597685
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Current development of the problem of "artificial blood"].
    Ivanov KP.
    Gematol Transfuziol; 1992 Feb; 37(2):26-9. PubMed ID: 1426905
    [No Abstract] [Full Text] [Related]

  • 28. Polymer/hemoglobin assemblies: biodegradable oxygen carriers for artificial red blood cells.
    Li T, Jing X, Huang Y.
    Macromol Biosci; 2011 Jul 07; 11(7):865-75. PubMed ID: 21312333
    [Abstract] [Full Text] [Related]

  • 29. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
    Cohn CS, Cushing MM.
    Crit Care Clin; 2009 Apr 07; 25(2):399-414, Table of Contents. PubMed ID: 19341916
    [Abstract] [Full Text] [Related]

  • 30. Massive transfusion--state of the art.
    Weinstabl C.
    Acta Anaesthesiol Scand Suppl; 1996 Apr 07; 109():79-80. PubMed ID: 8901956
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Blood substitutes: the future is now.
    Moore EE.
    J Am Coll Surg; 2003 Jan 07; 196(1):1-17. PubMed ID: 12517544
    [No Abstract] [Full Text] [Related]

  • 33. Artificial Oxygen Carrier as Therapeutics Rather Than Blood Substitute for Transfusion.
    Kawaguchi AT.
    Artif Organs; 2017 Apr 07; 41(4):312-315. PubMed ID: 28397405
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Use of perfluorane in the transfusion therapy of tuberculosis and other bronchopulmonary diseases].
    Zhilin IuN, Bakhmutova NV, Gamaev AE, Nabokova TS, Kaminskaia GO, Serebriannaia BA, Gus'kov MIu.
    Probl Tuberk; 2000 Apr 07; (1):18-21. PubMed ID: 10750422
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Recombinant hemoglobins as artificial oxygen carriers.
    Fronticelli C, Koehler RC, Brinigar WS.
    Artif Cells Blood Substit Immobil Biotechnol; 2007 Apr 07; 35(1):45-52. PubMed ID: 17364470
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.